Medical research

To treat rare disease, NIH scientists repurpose FDA-approved drug

A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known ...

Diseases, Conditions, Syndromes

Has the COVID-19 pandemic compromised bone health?

Results from a study published in the American Journal of Human Biology suggest that the COVID-19 pandemic has had negative effects on bone tissue—including both bone mineral density in the forearm and total bone mineral ...

page 15 from 18